| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.4M | +31.1% |
| Cost of Revenue | $3.1M | -7.1% |
| R&D Expense | $4.7M | -42.1% |
| SG&A Expense | $8.1M | -9.0% |
| Operating Income | -$30.7M | +11.0% |
| Interest Expense | $1.8M | -43.5% |
| Pre-tax Income | -$32.7M | +12.4% |
| Net Income | -$32.7M | +12.4% |
| EPS (Basic) | -$41.47 | -171.6% |
| EPS (Diluted) | -$41.47 | -171.6% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.2M | -84.5% |
| Accounts Receivable | $103K | -79.9% |
| Inventory | $3.6M | +0.0% |
| Current Assets | $1.6M | -85.2% |
| Total Assets | $1.9M | -92.7% |
| Current Liabilities | $11.4M | +7.8% |
| Long-term Debt | $4.9M | +0.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.3M | +30.0% |
| Capital Expenditures | $800K | +35.5% |
| Investing Cash Flow | -$800K | -35.5% |
| Financing Cash Flow | $8.4M | +224.3% |
| Free Cash Flow | -$15.1M | +28.1% |
| Total Liabilities |
| $13.4M |
| -26.3% |
| Stockholders' Equity | -$11.6M | -252.6% |